Skip to Content

BCMA-targeted and CAR-T cells therapies for multiple myeloma give a very exciting future and new hope for the patients

In this MEDtalk, Sagar Lonial, Chief Medical Officer, Winship Cancer Institute of Emory University, USA, gives his perspective on the explosion of new BCMA-targeted immune therapies and CAR-T cell therapies with encouraging data. These new treatment targets raise the question of how to sequence treatment. In this MEDtalk, you will get a fresh perspective from one of the leading experts.

Dr. Sagar Lonial

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top